跳至主要内容
临床试验/NCT01590173
NCT01590173已完成2 期

Addition of Prednisolone and Heparin in Patients With Repeated Implantation Failures: a Prospective Clinical Study

National and Kapodistrian University of Athens1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
86
试验地点
1
主要终点
clinical pregnancy rate

研究概览

简要总结

The addition of heparin and prednisolone increases pregnancy outcome parameters in women undergoing In Vitro Fertilisation (IVF) with failed IVF cycles.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • personal history of ≥2 failed IVF/ICSI cycles
  • age <45 years
  • availability of fresh ejaculate sperm for IVF/ICSI procedures
  • confirmation of normal uterine cavity
  • presence of good quality (Grade I or II) embryos for transfer

排除标准

  • endocrine disorders
  • immune disorders
  • coagulation disorders

研究组 & 干预措施

Prednisolone and Heparin during COH for IVF

Experimental

干预措施: Prednisolone and Heparin during COH for IVF (Drug)

COH for IVF

Active Comparator

干预措施: COH for IVF (Drug)

结局指标

主要结局

clinical pregnancy rate

时间窗: finding of a fetal heart at >6 gestational weeks / 2 years

次要结局

  • miscarriage rate(through study completion, an average of 2 years)
  • live birth rate(through study completion, an average of 2 years)
  • OHSS(through study completion, an average of 2 years)
  • multiple pregnancy rate(through study completion, an average of 2 years)
  • biochemical pregnancy rate(through study completion, an average of 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Siristatidis Charalampos, MD, PhD

Senior Lecturer, Director of the IVF Unit

National and Kapodistrian University of Athens

研究点 (1)

Loading locations...

相似试验